A smart molecule beats the mutation behind most pancreatic cancer
Scientists discover a new way to disarm a deadly protein that also appears in cancers of the lung, breast and colon.
UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.
The new molecule permanently modifies a wily cancer-causing mutation, called K-Ras G12D, that is responsible for nearly half of all pancreatic cancer cases and appears in some forms of lung, breast and colon cancer.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Pancreas | Pancreatic Cancer | Pharmaceuticals